# RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

> **NCT05965726** · PHASE2 · COMPLETED · sponsor: **Kanecia Obie Zimmerman** · enrollment: 964 (actual)

## Conditions studied

- Long COVID-19
- Long COVID

## Interventions

- **DRUG:** Paxlovid
- **DRUG:** Ritonavir
- **DRUG:** Nirmatrelvir-matching placebo

## Key facts

- **NCT ID:** NCT05965726
- **Lead sponsor:** Kanecia Obie Zimmerman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-26
- **Primary completion:** 2024-12-05
- **Final completion:** 2025-03-13
- **Target enrollment:** 964 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965726, "RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05965726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*